日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus

单克隆抗体疗法可保护非人类灵长类动物免受拉沙病毒的粘膜感染

Robert W Cross, Karla A Fenton, Courtney Woolsey, Abhishek N Prasad, Viktoriya Borisevich, Krystle N Agans, Daniel J Deer, Natalie S Dobias, Alyssa C Fears, Megan L Heinrich, Joan B Geisbert, Robert F Garry, Luis M Branco, Thomas W Geisbert

Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease

重组水泡性口炎病毒载体疫苗可诱导针对尼帕病毒病的持久免疫力

Courtney Woolsey, Viktoriya Borisevich, Alyssa C Fears, Krystle N Agans, Daniel J Deer, Abhishek N Prasad, Rachel O'Toole, Stephanie L Foster, Natalie S Dobias, Joan B Geisbert, Karla A Fenton, Robert W Cross, Thomas W Geisbert

A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection

基于重组水泡性口炎病毒的疫苗可提供针对本迪布焦埃博拉病毒感染的暴露后保护

Courtney Woolsey, Jamie Strampe, Karla A Fenton, Krystle N Agans, Jasmine Martinez, Viktoriya Borisevich, Natalie S Dobias, Daniel J Deer, Joan B Geisbert, Robert W Cross, John H Connor, Thomas W Geisbert

The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets

埃博拉糖蛋白的粘蛋白样结构域不会影响雪貂的毒力或致病性

Peter J Halfmann, Viktoriya Borisevich, Corri B Levine, Chad E Mire, Karla A Fenton, Thomas W Geisbert, Yoshihiro Kawaoka, Robert W Cross

A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses

基于重组嵌合雪松病毒的致病性亨尼巴病毒替代中和检测平台

Moushimi Amaya, Randy Yin, Lianying Yan, Viktoriya Borisevich, Bishwo N Adhikari, Andrew Bennett, Francisco Malagon, Regina Z Cer, Kimberly A Bishop-Lilly, Antony S Dimitrov, Robert W Cross, Thomas W Geisbert, Christopher C Broder

Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesis

α-1-抗胰蛋白酶及其变体依赖性在 COVID-19 发病机制中的作用

Christian S Stevens, Kasopefoluwa Y Oguntuyo, Shreyas Kowdle, Luca Brambilla, Griffin Haas, Aditya Gowlikar, Mohammed Na Siddiquey, Robert M Schilke, Matthew D Woolard, Hongbo Zhang, Joshua A Acklin, Satoshi Ikegame, Chuan-Tien Huang, Jean K Lim, Robert W Cross, Thomas W Geisbert, Stanimir S Ivanov,

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

高度减毒的 Vesiculovax 疫苗可迅速保护非人类灵长类动物免受致命的马尔堡病毒的攻击

Courtney Woolsey, Robert W Cross, Krystle N Agans, Viktoriya Borisevich, Daniel J Deer, Joan B Geisbert, Cheryl Gerardi, Theresa E Latham, Karla A Fenton, Michael A Egan, John H Eldridge, Thomas W Geisbert, Demetrius Matassov

Pan-ebolavirus protective therapy by two multifunctional human antibodies

两种多功能人类抗体的泛埃博拉病毒保护疗法

Pavlo Gilchuk, Charles D Murin, Robert W Cross, Philipp A Ilinykh, Kai Huang, Natalia Kuzmina, Viktoriya Borisevich, Krystle N Agans, Joan B Geisbert, Seth J Zost, Rachel S Nargi, Rachel E Sutton, Naveenchandra Suryadevara, Robin G Bombardi, Robert H Carnahan, Alexander Bukreyev, Thomas W Geisbert, 

Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever

克里米亚-刚果出血热幸存者体内的保护性中和抗体

J Maximilian Fels ,Daniel P Maurer ,Andrew S Herbert ,Ariel S Wirchnianski ,Olivia Vergnolle ,Robert W Cross ,Dafna M Abelson ,Crystal L Moyer ,Akaash K Mishra ,Jennifer T Aguilan ,Ana I Kuehne ,Noel T Pauli ,Russell R Bakken ,Elisabeth K Nyakatura ,Jan Hellert ,Gregory Quevedo ,Leslie Lobel ,Stephen Balinandi ,Julius J Lutwama ,Larry Zeitlin ,Thomas W Geisbert ,Felix A Rey ,Simone Sidoli ,Jason S McLellan ,Jonathan R Lai ,Zachary A Bornholdt ,John M Dye ,Laura M Walker ,Kartik Chandran

Establishment of an African green monkey model for COVID-19 and protection against re-infection

非洲绿猴新冠病毒感染模型的建立及对再次感染的防护

Courtney Woolsey, Viktoriya Borisevich, Abhishek N Prasad, Krystle N Agans, Daniel J Deer, Natalie S Dobias, John C Heymann, Stephanie L Foster, Corri B Levine, Liana Medina, Kevin Melody, Joan B Geisbert, Karla A Fenton, Thomas W Geisbert, Robert W Cross